Cargando…
Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients
There is strong evidence for an association between major depressive disorder (MDD) and inflammation. However, some studies have not observed an increase in inflammatory cytokines in MDD, and the mechanism behind this is unknown. In the present study, we evaluated MDD severity using the Montgomery–Å...
Autores principales: | Kobayashi, Nobuyuki, Shinagawa, Shunichiro, Nagata, Tomoyuki, Shigeta, Masahiro, Kondo, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315526/ https://www.ncbi.nlm.nih.gov/pubmed/35887537 http://dx.doi.org/10.3390/jpm12071040 |
Ejemplares similares
-
A case of V180I genetic mutation Creutzfeldt Jakob disease (CJD) with delusional misidentification as an initial symptom
por: Nagata, Tomoyuki, et al.
Publicado: (2021) -
Blood DNA Methylation Levels in the WNT5A Gene Promoter Region: A Potential Biomarker for Agitation in Subjects with Dementia
por: Kobayashi, Nobuyuki, et al.
Publicado: (2021) -
Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2022) -
Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease
por: Kobayashi, Nobuyuki, et al.
Publicado: (2020) -
Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)